NMC
ZBIO

NEA Management Company’s Zenas BioPharma ZBIO Stock Holding History

NEA Management Company’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.7M Buy
4,023,219
+500,000
+14% +$11.2M 4.47% 8
2025
Q4 		$128M Buy
3,523,219
+789,500
+29% +$26M 6.52% 6
2025
Q3 		$60.7M Hold
2,733,719
– – 3.33% 10
2025
Q2 		$26.5M Buy
2,733,719
+119,771
+5% +$1.17M 1.99% 13
2025
Q1 		$20.7M Hold
2,613,948
– – 1.59% 13
2024
Q4 		$21.4M Hold
2,613,948
– – 1.21% 15
2024
Q3 		$44.2M Buy
+2,613,948
New +$47M 2.41% 10

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NEA Management Company's ZBIO Position: Q1 2026 in Review

NEA Management Company increased its Zenas BioPharma (ZBIO) stake by 14% in Q1 2026, buying an estimated $11.2M and bringing the position to 4,023,219 shares worth $78.7M. The position accounts for 4.47% of the portfolio, ranked #8.

NEA Management Company first reported a position in ZBIO in Q3 2024 and has held it in 7 quarters since. The position peaked at $128M in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • NEA Management Company held 4,023,219 shares of Zenas BioPharma worth $78.7M as of Q1 2026.
  • NEA Management Company bought 500,000 Zenas BioPharma shares in Q1 2026, an estimated $11.2M.
  • Zenas BioPharma made up 4.47% of NEA Management Company's portfolio in Q1 2026, its #8 holding.
  • NEA Management Company first reported a position in Zenas BioPharma in Q3 2024 and has held it in 7 quarters since.
  • NEA Management Company's Zenas BioPharma position peaked at $128M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.